In NAFLD, Th2 cells that produce IL-4 and/or IL-13 seem to exert anti-inflammatory effects, but the immune mechanisms mediated by Th2 cells in NAFLD and NASH are still unclear (43). The gene discussed is IL4; the disease is metabolic dysfunction-associated steatotic liver disease.